Author

C. Choisy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Domenger· 1 shared B. Arnulf· 1 shared C. Demangel· 1 shared G. Dadaglio· 1 shared J.-C. Bories· 1 shared L. Baron· 1 shared L. Deriano· 1 shared V. Mayau· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Domenger

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The Sec61 translocon is a therapeutic vulnerability in Multiple Myeloma

A. Domenger, C. Choisy, L. Baron, V. Mayau, L. Deriano, B. Arnulf, J.-C. Bories, G. Dadaglio, C. Demangel

This study shows that targeting the Sec61 translocon with mycolactone enhances the effectiveness of bortezomib in killing multiple myeloma cells and reduces toxicity.

bioRxiv · Sep 5, 2021Cancer Biology